The fluorescent labeling compound—dubbed "Sialyl Lewis Yellow"—was developed by an international team led from the Pohang University of Science and Technology in South Korea. It works by binding to ...

Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the ...

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 ...

The Chan Zuckerberg Initiative (CZI) reports its latest AI model aimed at helping researchers better understand how cells ...

In a bid to better understand how cancer cells power their explosive growth and spread, scientists at Johns Hopkins Medicine ...

In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...

Studies show in mice show that targeting the metabolic pathways could inhibit the growth of melanoma and combining this ...

Could a legendary tomb curse become a medical miracle? Scientists may have reengineered Aspergillus flavus, linked to King ...

The two types of uterine cancer are endometrial cancer and uterine sarcoma. Each of these types has several subtypes.

Each time a cell divides, a small section of each chromosome's protective cap—the telomere—is worn away. Most cells use an ...

A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically ...